心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2015 ESC专家共识：老年人抗血栓治疗

2015-07-09 欧洲心脏病学会 Eur Heart J. 2015 Jul 9.

老年人抗血栓治疗

急性冠脉综合征（ACS）和房颤多发于老年人，是双联抗血小板或抗凝治疗的常见适应证。超过1/3的急性心梗住院和2/3的心梗死亡发生于75岁以上的老年人，然而只有不到7%的ACS试验报告纳入了75岁以上的老年人。老年人常伴有多器官变化及多种疾病，出血性和缺血性事件风险增加，常服用多种药物，对治疗的依从性差，因此为临床管理带来很大的挑战。好消息是，近年来，抗栓的新药不断涌现。2015年7月9日，欧洲心脏

中文标题：

2015 ESC专家共识：老年人抗血栓治疗

英文标题：

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

发布机构：

欧洲心脏病学会

发布日期：

2015-07-09

简要介绍：

急性冠脉综合征（ACS）和房颤多发于老年人，是双联抗血小板或抗凝治疗的常见适应证。超过1/3的急性心梗住院和2/3的心梗死亡发生于75岁以上的老年人，然而只有不到7%的ACS试验报告纳入了75岁以上的老年人。老年人常伴有多器官变化及多种疾病，出血性和缺血性事件风险增加，常服用多种药物，对治疗的依从性差，因此为临床管理带来很大的挑战。好消息是，近年来，抗栓的新药不断涌现。2015年7月9日，欧洲心脏病学会（ESC）血栓工作组制定的《老年人抗栓治疗专家意见书》发表于《European Heart Journal》。

相关资料下载：
[AttachmentFileName(sort=100, fileName=2015 ESC专家共识：老年人抗血栓治疗)] GetToolGuiderByIdResponse(projectId=1, id=8ccc91c001332358, title=2015 ESC专家共识：老年人抗血栓治疗, enTitle=Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis., guiderFrom=Eur Heart J. 2015 Jul 9., authorId=null, author=, summary=急性冠脉综合征（ACS）和房颤多发于老年人，是双联抗血小板或抗凝治疗的常见适应证。超过1/3的急性心梗住院和2/3的心梗死亡发生于75岁以上的老年人，然而只有不到7%的ACS试验报告纳入了75岁以上的老年人。老年人常伴有多器官变化及多种疾病，出血性和缺血性事件风险增加，常服用多种药物，对治疗的依从性差，因此为临床管理带来很大的挑战。好消息是，近年来，抗栓的新药不断涌现。2015年7月9日，欧洲心脏, cover=, journalId=null, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会，会员超过70000人、提供更新指南、调查数据、组织学术会议，ESC年会是心血管领域最大的会议。下设5个分会（超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会）。提供指南较全面，按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Thu Jul 09 00:00:00 CST 2015, originalUrl=, linkOutUrl=, content=急性冠脉综合征（ACS）和房颤多发于老年人，是双联抗血小板或抗凝治疗的常见适应证。超过1/3的急性心梗住院和2/3的心梗死亡发生于75岁以上的老年人，然而只有不到7%的ACS试验报告纳入了75岁以上的老年人。老年人常伴有多器官变化及多种疾病，出血性和缺血性事件风险增加，常服用多种药物，对治疗的依从性差，因此为临床管理带来很大的挑战。好消息是，近年来，抗栓的新药不断涌现。2015年7月9日，欧洲心脏病学会（ESC）血栓工作组制定的《老年人抗栓治疗专家意见书》发表于《European Heart Journal》。<div><br> 拓展指南：<strong>与<font color="red">抗血栓治疗</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=0d0ec1c00128e53c" title="2015 EHRA立场文件：接受心脏电生理手术患者的抗血栓治疗" target="_blank">2015 EHRA立场文件：接受心脏电生理手术患者的抗血栓治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c40331c0011a3204" title="2014 韩国心律学会声明：非瓣膜性房颤患者的抗血栓治疗" target="_blank">2014 韩国心律学会声明：非瓣膜性房颤患者的抗血栓治疗</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E6%8A%97%E8%A1%80%E6%A0%93%E6%B2%BB%E7%96%97" target="_blank">有关抗血栓治疗更多指南</a></ul></div>, tagList=[TagDto(tagId=2575, tagName=老年人), TagDto(tagId=29144, tagName=抗血栓治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3258, appHits=282, showAppHits=0, pcHits=2022, showPcHits=1257, likes=169, shares=13, comments=5, approvalStatus=1, publishedTime=Tue Nov 22 11:28:17 CST 2016, publishedTimeString=2015-07-09, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Tue Nov 22 11:28:17 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 16:24:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2015 ESC专家共识：老年人抗血栓治疗)])
2015 ESC专家共识：老年人抗血栓治疗
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057473, encodeId=fbdb105e473ec, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:57:13 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165551, encodeId=26ed1655514b, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 25 11:01:58 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160716, encodeId=5e40160e163b, content=很好?学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/500fb0522c49411a993af4fd64f0b4a1/33d6c69db19f47138b3abca21d043b69.jpg, createdBy=a0501991324, createdName=fay370, createdTime=Tue Dec 06 16:39:48 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157511, encodeId=a3f715e5119e, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:30:46 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157476, encodeId=a93415e4767d, content=挺好的，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Tue Nov 22 18:33:24 CST 2016, time=2016-11-22, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057473, encodeId=fbdb105e473ec, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:57:13 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165551, encodeId=26ed1655514b, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 25 11:01:58 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160716, encodeId=5e40160e163b, content=很好?学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/500fb0522c49411a993af4fd64f0b4a1/33d6c69db19f47138b3abca21d043b69.jpg, createdBy=a0501991324, createdName=fay370, createdTime=Tue Dec 06 16:39:48 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157511, encodeId=a3f715e5119e, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:30:46 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157476, encodeId=a93415e4767d, content=挺好的，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Tue Nov 22 18:33:24 CST 2016, time=2016-11-22, status=1, ipAttribution=)]
    2016-12-25 ylzr123

    很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057473, encodeId=fbdb105e473ec, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:57:13 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165551, encodeId=26ed1655514b, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 25 11:01:58 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160716, encodeId=5e40160e163b, content=很好?学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/500fb0522c49411a993af4fd64f0b4a1/33d6c69db19f47138b3abca21d043b69.jpg, createdBy=a0501991324, createdName=fay370, createdTime=Tue Dec 06 16:39:48 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157511, encodeId=a3f715e5119e, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:30:46 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157476, encodeId=a93415e4767d, content=挺好的，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Tue Nov 22 18:33:24 CST 2016, time=2016-11-22, status=1, ipAttribution=)]
    2016-12-06 fay370

    很好?学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057473, encodeId=fbdb105e473ec, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:57:13 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165551, encodeId=26ed1655514b, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 25 11:01:58 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160716, encodeId=5e40160e163b, content=很好?学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/500fb0522c49411a993af4fd64f0b4a1/33d6c69db19f47138b3abca21d043b69.jpg, createdBy=a0501991324, createdName=fay370, createdTime=Tue Dec 06 16:39:48 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157511, encodeId=a3f715e5119e, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:30:46 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157476, encodeId=a93415e4767d, content=挺好的，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Tue Nov 22 18:33:24 CST 2016, time=2016-11-22, status=1, ipAttribution=)]
    2016-11-22 zibozhouping

    I make a great progress I have gained a lot

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057473, encodeId=fbdb105e473ec, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:57:13 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165551, encodeId=26ed1655514b, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 25 11:01:58 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160716, encodeId=5e40160e163b, content=很好?学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/500fb0522c49411a993af4fd64f0b4a1/33d6c69db19f47138b3abca21d043b69.jpg, createdBy=a0501991324, createdName=fay370, createdTime=Tue Dec 06 16:39:48 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157511, encodeId=a3f715e5119e, content=I make a great progress I have gained a lot, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Nov 22 21:30:46 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=157476, encodeId=a93415e4767d, content=挺好的，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Tue Nov 22 18:33:24 CST 2016, time=2016-11-22, status=1, ipAttribution=)]
    2016-11-22 susice

    挺好的，学习了

    0

相关指南

2015 AHA科学声明：老年人先天性心脏病

美国心脏协会(AHA,American Heart Association) · 2015-04-20

2016 老年人非瓣膜性心房颤动诊治中国专家建议

中华医学会老年医学分会 · 2016-09-30

2015 NICE指南：居家老年人的家庭护理（NG.21）

暂未更新 · 2015-09-17

2015 NICE指南：老年人社会保健需求和多样性长期条件（NG.22）

暂未更新 · 2015-11-04

2015 NICE指南：老年人独立和心理健康（NG.32）

暂未更新 · 2015-12-17

2016 ANZSGM立场声明：营养不良和老年人

暂未更新 · 2016-06-29